Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00508014 · ClinicalTrials.gov registry record · NA

Assessing the Effectiveness of Concurrent Peer Review for Patients With Cardiovascular Disease and Diabetes

A NA study of Cardiovascular Diseases, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
727
Enrollment target
1
Study location

NCT00508014 is a NA study of Cardiovascular Diseases that has completed, run by University of Rochester. The registered enrollment target is 727 participants, below the 26,972-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00508014, a NA study of Cardiovascular Diseases, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
727 participants
Enrollment target
1
Study location

Study Summary

We will assess the impact of concurrent peer review vists on blood pressure, cholesterol and diabetes control. Concurrent peer review (CPR) visits refer to special offic visits by patients to a clinician (physician, nurse practitioner, or physician assistant) other than than their primary care provider that are specifically designed to improve care for diabetes and cardiovascular disease.

Conditions Studied

Interventions

  • OTHER Usual Care
  • BEHAVIORAL Concurrent Peer Review visit

Study Locations (1)

New York

  • Westside Health Services, Inc - Rochester

Trial Details

FieldValue
Enrollment Target 727 participants
Start Date 2006-12
Est. Completion 2010-06
Phase NA

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT00508014

The ClinicalTrials.gov registry entry for NCT00508014 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 727 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,972-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (97% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT00508014 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00508014 about?

NCT00508014 is a clinical study titled "Assessing the Effectiveness of Concurrent Peer Review for Patients With Cardiovascular Disease and Diabetes". We will assess the impact of concurrent peer review vists on blood pressure, cholesterol and diabetes control. Concurrent peer review (CPR) visits refer to special offic visits by patients to a clinician (physician, nurse practitioner, or physician assistant) other than than their primary care provi...

What is the current status of trial NCT00508014?

This trial is currently completed. It is a NA study. The enrollment target is 727 participants. The study started on 2006-12. Estimated completion is 2010-06.

What conditions does trial NCT00508014 study?

This clinical trial studies the following conditions: Cardiovascular Diseases.

What interventions are being tested in trial NCT00508014?

The interventions under investigation include: Usual Care (OTHER), Concurrent Peer Review visit (BEHAVIORAL).

Who is sponsoring clinical trial NCT00508014?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00508014 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.